HealthCCSng vs qXR-CTR
AI Verdict
Choose HealthCCSng if…
Choose HealthCCSng if your primary objective is to proactively identify patients at risk of coronary artery disease by automatically detecting and quantifying coronary artery calcification (CAC) from routine CT scans. This tool is ideal for integrating into existing radiology workflows to provide objective, AI-powered cardiovascular risk stratification without requiring dedicated cardiac CTs.
View HealthCCSng →Choose qXR-CTR if…
Choose qXR-CTR if you require an efficient, AI-powered solution to automate the measurement of the cardiothoracic ratio (CTR) from standard chest X-ray images. This tool is best suited for rapid screening and initial assessment of heart size and potential heart failure risk in settings where chest X-rays are a common and accessible diagnostic modality.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HealthCCSng | qXR-CTR |
|---|---|---|
| Pricing | Not publicly available | Unknown |
| Deployment | Cloud-based, integrates with PACS and EMR systems | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRWhile both tools emphasize seamless integration with PACS and EMR systems, qXR-CTR (as part of the broader qXR suite) offers a more comprehensive set of user-centric features. These include pre-read assistance, AI overlays, templated reports, a DICOM viewer, worklist management, and mobile/desktop access, suggesting a richer and more interactive user experience compared to HealthCCSng's focus on automated results and integration.
Clinical Value
HealthCCSngBoth tools offer significant clinical value with FDA clearance. However, HealthCCSng stands out by opportunistically detecting and quantifying coronary artery calcification (CAC) from routine, non-contrast, non-ECG gated chest CT scans, which are often performed for other indications. This approach identifies a large, previously undetected population at risk for coronary artery disease without additional dedicated scans or radiation, offering a unique advantage in preventive cardiac care.
Pricing & Value
HealthCCSngNeither tool publicly discloses pricing, making a direct cost comparison impossible. However, HealthCCSng explicitly mentions established CPT codes (0721T & 0722T) for reimbursement and has demonstrated its ability to drive significant revenue for cardiology departments. This provides a clearer and more tangible path to financial value for healthcare providers.
Enterprise Readiness
qXR-CTRqXR-CTR offers superior enterprise readiness due to its flexible deployment options, including cloud, on-premise, and hybrid models, catering to diverse IT infrastructures and data residency needs. Furthermore, Qure.ai lists numerous major integration partners and holds ISO 27001 certification, indicating a robust and secure solution suitable for large-scale healthcare environments.
Innovation
HealthCCSngWhile both leverage AI, HealthCCSng demonstrates a higher degree of innovation by analyzing routine, non-cardiac-gated CT scans to detect coronary artery calcification. This 'opportunistic screening' method re-purposes existing imaging data, enabling widespread identification of a critical cardiac risk factor without requiring new, dedicated scans, thereby increasing early detection efficiency and reducing patient burden.
Support & Docs
qXR-CTRQure.ai, the company behind qXR-CTR, provides extensive details on its support structure, including dedicated client success partners, personalized onboarding, training programs, regular webinars, and 24/7 support. In contrast, no specific information regarding support or documentation for HealthCCSng is publicly available in the provided data or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HealthCCSng | qXR-CTR |
|---|---|---|
| Name | HealthCCSng | qXR-CTR |
| Company | Nano-X AI | Qure.ai Technologies |
| Description | HealthCCSng is an FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. | qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Primary Imaging Modality | CT scans | Chest X-ray images |
| Key Functionality | Automatically detects and quantifies coronary artery calcification (CAC), categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, generates a numerical calcium score, provides visualization of calcified plaques. | Automates the measurement of the cardiothoracic ratio (CTR). |
Videos
Demos, reviews, and walkthroughs featuring HealthCCSng and qXR-CTR.